Bivalirudin started during transport for primary percutaneous coronary intervention ( PCI ) for ST-segment elevation myocardial infarction significantly reduced major bleeding compared with heparin with or without glycoprotein IIb/IIIa inhibitors ( GPI ) , but it was associated with an increase in AST .